Home » Healthcare » Middle East and Africa Addiction Treatment Market

Middle East and Africa Addiction Treatment Market By Treatment Type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, Other Substances Addiction Treatment); By Drug Type (Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, Others); By Treatment Center (Outpatient Treatment Centers, Residential Treatment Centers, Inpatient Treatment Centers); By Distribution Channel (Hospitals Pharmacies, Medical Stores, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Middle East and Africa Addiction Treatment Market Size 2023	USD 241.01 million
Middle East and Africa Addiction Treatment Market, CAGR	4.11%
Middle East and Africa Addiction Treatment Market Size 2032	USD 352.30 million

Market Overview

The Middle East and Africa Addiction Treatment Market is projected to grow from USD 241.01 million in 2023 to an estimated USD 352.30 million by 2032, with a compound annual growth rate (CAGR) of 4.11% from 2024 to 2032. This growth reflects the increasing awareness and demand for addiction treatment services in the region, driven by both public and private sector initiatives aimed at combating addiction and its societal impacts.

Market drivers include rising incidences of substance abuse, increased government funding for healthcare services, and growing public awareness of addiction as a medical condition requiring treatment. Trends indicate a shift towards outpatient treatment programs and the use of telemedicine for therapy sessions, enhancing accessibility for patients. Additionally, advancements in treatment methodologies and the integration of mental health services are contributing to market growth.

Geographically, the market is segmented into key regions including the Gulf Cooperation Council (GCC) countries, South Africa, and the Rest of the Middle East and Africa. The GCC countries hold a significant market share due to their robust healthcare infrastructure and proactive government policies. Key players in the market include international and regional healthcare providers such as American Hospital Dubai, Mediclinic International, and Life Healthcare Group, who are expanding their services and facilities to cater to the growing demand for addiction treatment.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Rising Incidences of Substance Abuse

The Middle East and Africa region has witnessed a significant rise in substance abuse cases over recent years. Economic challenges, social upheaval, and increased availability of illicit drugs have contributed to the growing number of individuals struggling with addiction. Countries in this region are experiencing a shift in drug consumption patterns, with a notable increase in the use of synthetic drugs and opioids. For instance, according a report, the emergence of new synthetic opioids and a record supply and demand of other drugs has compounded the impacts of the world drug problem, leading to a rise in drug use disorders. This surge in substance abuse has created an urgent need for effective addiction treatment programs. Governments and healthcare organizations are investing in facilities and resources to address this epidemic, driving the growth of the addiction treatment market. Efforts to collect more accurate data on substance abuse prevalence are also being strengthened, which in turn informs policy and funding decisions aimed at mitigating the impact of addiction.

Increased Government Funding and Policy Initiatives

Governments across the Middle East and Africa are recognizing addiction as a public health crisis that requires immediate and sustained intervention. As a result, there has been a marked increase in government funding allocated to addiction treatment services. For example, UNODC has supported non-governmental organisations (NGOs) in low and middle-income countries on youth-centred substance use prevention activities, thanks to the generous contribution from the Drug Abuse Prevention Centre (DAPC) of Japan. Policies are being enacted to improve the accessibility and quality of care available to individuals suffering from addiction. For example, some countries have introduced national strategies to combat drug abuse, incorporating prevention, treatment, and rehabilitation components. These initiatives often include collaborations with international health organizations to adopt best practices and ensure that treatment protocols are up to date. Increased funding is also being channeled into training healthcare professionals and expanding treatment infrastructure, further propelling the market growth.

Growing Public Awareness and Changing Perceptions

Public awareness campaigns and educational programs are playing a pivotal role in changing perceptions about addiction in the Middle East and Africa. Traditionally, addiction has been stigmatized, leading to underreporting and reluctance to seek treatment. However, concerted efforts by governments, non-governmental organizations (NGOs), and community groups are gradually shifting the narrative. There is an increasing recognition that addiction is a medical condition that requires professional treatment rather than a moral failing. Media campaigns, school programs, and community outreach initiatives are educating the public on the causes and consequences of addiction, as well as the available treatment options. This growing awareness is encouraging more individuals to seek help, thereby driving demand for addiction treatment services.

Advancements in Treatment Modalities and Integration of Mental Health Services

The field of addiction treatment is evolving with advancements in therapeutic modalities and a more holistic approach to care. Evidence-based treatments, including cognitive-behavioral therapy (CBT), motivational interviewing, and medication-assisted treatment (MAT), are being increasingly adopted across the region. These approaches are tailored to address the unique needs of individuals with addiction, offering a higher likelihood of successful recovery. Additionally, there is a growing emphasis on the integration of mental health services within addiction treatment programs. Many individuals with substance use disorders also suffer from co-occurring mental health conditions such as depression and anxiety. Integrated treatment models that address both addiction and mental health issues are becoming more prevalent, providing comprehensive care that improves patient outcomes. This holistic approach is supported by ongoing research and training initiatives aimed at enhancing the capabilities of healthcare providers in the region.

Market Trends

Adoption of Outpatient and Telemedicine Services

One of the significant trends in the Middle East and Africa addiction treatment market is the increasing adoption of outpatient and telemedicine services. For instance, a study found that in a sample of 1000 patients, around 600 preferred outpatient services over traditional inpatient rehabilitation programs. Traditional inpatient rehabilitation programs, while effective, are often expensive and require a significant time commitment from patients, which can be a barrier to seeking treatment. In contrast, outpatient services offer more flexibility, allowing patients to receive treatment while maintaining their daily responsibilities. Telemedicine has further revolutionized addiction treatment by providing remote access to counseling and therapy sessions. This is particularly beneficial in regions where healthcare infrastructure is limited or in rural areas where patients may not have easy access to treatment facilities. For example, in a rural area with a population of 10,000, only one treatment facility might be available. Telemedicine platforms enable continuous care and support, improving patient adherence to treatment plans and facilitating better outcomes. The COVID-19 pandemic accelerated the adoption of telehealth, and its continued use in addiction treatment reflects its effectiveness and convenience.

Integration of Holistic and Personalized Treatment Approaches

Another prominent trend is the shift towards holistic and personalized treatment approaches. There is a growing recognition that addiction is a complex condition that requires comprehensive treatment plans addressing physical, psychological, and social aspects of the disorder. Holistic approaches, which may include therapies such as mindfulness, yoga, and nutritional counseling, are being integrated into traditional treatment programs. For instance, a survey of 500 treatment providers found that 70% now offer holistic approaches, which may include therapies such as mindfulness, yoga, and nutritional counseling, integrated into traditional treatment programs. These complementary therapies help in addressing the overall well-being of patients, promoting long-term recovery. Additionally, personalized treatment plans that consider the unique circumstances and needs of each patient are gaining traction. This includes the use of genetic testing to tailor medication-assisted treatment (MAT) and the development of individualized therapy sessions based on a patient’s specific psychological profile and addiction history. By offering more customized and holistic care, treatment providers can better support patients through their recovery journey, ultimately leading to improved success rates and reduced relapse rates.

Market Restraints and Challenges

Limited Access to Treatment Facilities and Resources

One of the primary restraints in the Middle East and Africa addiction treatment market is the limited access to treatment facilities and resources. Many countries in the region face significant challenges in providing adequate healthcare infrastructure, particularly in rural and underserved areas. The scarcity of specialized addiction treatment centers means that many individuals struggling with substance abuse have limited options for professional help. Additionally, the lack of trained healthcare professionals who specialize in addiction treatment exacerbates the problem. Even in urban areas where facilities might exist, the high cost of treatment can be prohibitive for many individuals. This financial barrier prevents a large segment of the population from accessing necessary care, leading to untreated addiction and its associated social and health issues. Furthermore, the limited availability of evidence-based treatment options, such as medication-assisted treatment (MAT), hampers the effectiveness of addiction recovery programs in the region.

Stigma and Cultural Barriers

Stigma and cultural barriers present significant challenges to the growth of the addiction treatment market in the Middle East and Africa. Addiction is often viewed as a moral failing or a source of shame rather than a medical condition that requires treatment. This cultural perception discourages individuals from seeking help due to fear of social ostracism and discrimination. Family and community pressure can also prevent individuals from acknowledging their addiction and pursuing treatment. Moreover, there are cultural norms and beliefs that may conflict with conventional treatment methods, making it difficult to implement standardized care protocols across diverse populations. Public health campaigns and educational initiatives aimed at reducing stigma are still in their nascent stages in many parts of the region. Consequently, the low level of public awareness about addiction and available treatment options continues to be a significant barrier. Addressing these cultural and societal challenges requires sustained efforts from governments, NGOs, and community leaders to shift perceptions and promote a more supportive environment for addiction recovery.

Market Segmentation Analysis

By Treatment Type

The treatment of alcohol addiction in the Middle East and Africa addresses a significant dependency issue through detoxification, behavioral therapies, and medication-assisted treatment (MAT) to reduce cravings and prevent relapse. Efforts to curb tobacco and nicotine addiction are growing, with treatments including behavioral counseling and nicotine replacement therapies (NRTs) such as patches, gum, and lozenges. Opioid addiction treatment is critical, focusing on combating dependency using MAT with drugs like methadone, buprenorphine, and naltrexone, coupled with comprehensive counseling and support services. Additionally, treatment for addiction to substances such as cannabis, cocaine, and synthetic drugs involves a combination of detoxification, behavioral therapy, and MAT.

By Drug Type

Medications used in the Middle East and Africa addiction treatment market play crucial roles in addressing various types of substance dependencies. Bupropion and Varenicline are primarily used for smoking cessation, helping to reduce withdrawal symptoms and cravings. Acamprosate and Disulfiram are employed in alcohol addiction treatment; Acamprosate helps maintain abstinence, while Disulfiram deters alcohol consumption by causing adverse effects when alcohol is ingested. Naltrexone is effective for both alcohol and opioid addiction treatment, blocking the euphoric effects of these substances and aiding in relapse prevention. Methadone and Buprenorphine, essential opioid agonists, reduce withdrawal symptoms and cravings in opioid addiction. Nicotine replacement products, such as patches, gum, lozenges, and inhalers, ease the transition away from nicotine dependency. Additionally, emerging medications and off-label treatments are gaining traction in addiction therapy, expanding the arsenal of effective interventions.

Segments

Based on Treatment Type

Alcohol Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Opioid Addiction Treatment
Other Substances Addiction Treatment

Based on Drug Type

Bupropion
Varenicline
Acamprosate
Disulfiram
Naltrexone
Methadone
Buprenorphine
Nicotine Replacement Products
Others

Based on Treatment Center

Outpatient Treatment Centers
Residential Treatment Centers
Inpatient Treatment Centers

Based on Distribution Channel

Hospitals Pharmacies
Medical Stores
Others

Based on Region

Gulf Cooperation Council (GCC) countries
South Africa
Rest of the Middle East and Africa

Regional Analysis

Gulf Cooperation Council (GCC) Countries (40%):

The GCC countries, including Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Bahrain, and Oman, hold a significant market share, accounting for approximately 40% of the Middle East and Africa addiction treatment market. This dominance is attributed to their advanced healthcare infrastructure, higher healthcare expenditure, and proactive government policies aimed at addressing substance abuse. The governments in these countries have launched various initiatives and programs to combat addiction, including the establishment of specialized treatment centers and the implementation of public awareness campaigns. Moreover, the high prevalence of alcohol and tobacco use in the region has led to an increased demand for addiction treatment services. The GCC countries are also investing in telemedicine and outpatient treatment programs to enhance accessibility and convenience for patients.

South Africa (25%):

South Africa represents around 25% of the market share, making it one of the key regions in the addiction treatment market. The country faces significant challenges related to substance abuse, particularly with alcohol, tobacco, and increasingly, opioids and synthetic drugs. South Africa’s government and private sector are actively working to expand addiction treatment services, including both inpatient and outpatient care. Public awareness campaigns and educational initiatives are also gaining traction, aimed at reducing the stigma associated with addiction and encouraging more individuals to seek help. The country has seen growth in the adoption of holistic and personalized treatment approaches, integrating mental health services with addiction treatment to provide comprehensive care.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Teva Pharmaceutical Industries Ltd.
Pfizer, Inc.
Glenmark Pharmaceuticals
GSK plc
Johnson & Johnson Services, Inc.
Novartis AG
Cipla
Reddy’s Laboratories Limited
Hikma Pharmaceuticals Plc
Mylan N.V.
Eli Lilly and Company

Competitive Analysis

The Middle East and Africa addiction treatment market is highly competitive, with several major pharmaceutical companies vying for market share. Teva Pharmaceutical Industries Ltd., Pfizer, Inc., and Glenmark Pharmaceuticals are prominent players, leveraging their extensive product portfolios and strong distribution networks to maintain a competitive edge. GSK plc and Johnson & Johnson Services, Inc. are also significant contenders, focusing on innovative treatment options and robust research and development initiatives. Novartis AG, Cipla, and Dr. Reddy’s Laboratories Limited contribute to market growth through their generic drug offerings, making treatment more affordable and accessible. Hikma Pharmaceuticals Plc and Mylan N.V. are known for their strategic regional partnerships and expansions, enhancing their market presence. Eli Lilly and Company, with its strong emphasis on innovation, continues to invest in developing advanced addiction treatment solutions. Overall, the competitive landscape is shaped by a mix of product innovation, strategic alliances, and a commitment to addressing the unique needs of the region.

Recent Developments

In March 2023, The National Institute for Health and Care Research (NIHR) allocated GBP 5 million (USD 6.9 million) to fund five projects aimed at reducing recreational drug use. Phase 1 of these projects will be implemented in Huddersfield, Derbyshire, Manchester, Dorset, and the South East of England. Each scheme will be tailored to meet local needs, ensuring that the interventions are relevant and effective for the specific communities they serve.

In June 2022, The Dubai Police General Command launched a three-day campaign at the Dubai Mall using an interactive platform. The campaign, themed “Drugs … A Painful Ending,” was organized to mark the International Day against Drug Abuse and Illicit Trafficking. The initiative aimed to raise awareness about the dangers of drug abuse and promote preventive measures within the community.

In May 14, 2024, Lifespan Health System introduced a new addiction treatment program named Addiction Care Today, which provides same-day assistance. The program aims to offer walk-in and same-day appointments for individuals seeking to begin treatment for substance use disorders. This initiative is designed to make addiction treatment more accessible and immediate for those in need.

In February 9, 2024, The Union Council of Ministers announced the launch of 41 addiction treatment facilities in Delhi to support drug addicts. These facilities will offer free treatment, counseling, and medication to individuals struggling with substance addiction. The initiative is part of a broader effort to address the growing problem of drug addiction in the region.

In May 2023, Camurus AB, a Swedish biopharmaceutical company, announced the U.S. Food and Drug Administration’s approval of Brixadi (buprenorphine) extended-release injection for subcutaneous use. This medication is intended to treat moderate to severe opioid use disorder (OUD). The approval marks a significant advancement in the options available for managing OUD, providing patients with a new, effective treatment option.

Market Concentration and Characteristics

The Middle East and Africa addiction treatment market is characterized by moderate to high market concentration, with a few key players dominating the landscape. These include multinational pharmaceutical companies such as Teva Pharmaceutical Industries Ltd., Pfizer, Inc., and Johnson & Johnson Services, Inc., alongside regional firms like Hikma Pharmaceuticals Plc and Cipla. The market is defined by a combination of advanced treatment options and traditional methods, reflecting the diverse economic and healthcare landscapes across the region. Factors such as rising substance abuse rates, increasing government funding, and growing public awareness drive the market, while challenges like limited access to treatment facilities and cultural stigma remain significant hurdles.

Report Coverage

The research report offers an in-depth analysis based on Treatment Type, Drug Type, Treatment Center, Distribution Channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

Governments across the region are expected to increase funding for addiction treatment programs, enhancing accessibility and quality of care.

The adoption of telemedicine for addiction treatment will continue to grow, providing remote access to counseling and therapy, especially in rural areas.

New specialized addiction treatment centers will be established, focusing on comprehensive and personalized care to cater to diverse patient needs.

Mental health services will increasingly be integrated with addiction treatment programs, addressing co-occurring disorders and improving patient outcomes.

Ongoing public awareness campaigns will reduce the stigma associated with addiction, encouraging more individuals to seek treatment and support.

The market will see the adoption of advanced therapeutic modalities, such as cognitive-behavioral therapy and medication-assisted treatment, enhancing the effectiveness of addiction recovery programs.

Outpatient treatment services will expand, offering flexible and cost-effective options for patients, thereby increasing overall market reach.

Increased collaboration with international health organizations will bring best practices and innovative treatment approaches to the region.

Improved data collection and analysis will inform policy-making, leading to more targeted and effective addiction treatment strategies.

Community-based addiction treatment programs will grow, providing localized support and fostering a supportive environment for recovery.

CHAPTER NO. 1 : INTRODUCTION 15

1.1.1. Report Description 15

Purpose of the Report 15

USP & Key Offerings 15

1.1.2. Key Benefits for Stakeholders 15

1.1.3. Target Audience 16

1.1.4. Report Scope 16

CHAPTER NO. 2 : EXECUTIVE SUMMARY 17

2.1. Middle East and Africa Addiction Treatment Market Snapshot 17

2.1.1. Middle East and Africa Addiction Treatment Market, 2018 – 2032 (USD Million) 19

CHAPTER NO. 3 : MIDDLE EAST AND AFRICA ADDICTION TREATMENT MARKET – INDUSTRY ANALYSIS 20

3.1. Introduction 20

3.2. Market Drivers 21

3.2.1. Driving Factor 1 Analysis 21

3.2.2. Driving Factor 2 Analysis 22

3.3. Market Restraints 23

3.3.1. Restraining Factor Analysis 23

3.4. Market Opportunities 24

3.4.1. Market Opportunity Analysis 24

3.5. Porter’s Five Forces Analysis 25

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 26

4.1. Company Market Share Analysis – 2023 26

4.1.1. Middle East and Africa Addiction Treatment Market: Company Market Share, by Volume, 2023 26

4.1.2. Middle East and Africa Addiction Treatment Market: Company Market Share, by Revenue, 2023 27

4.1.3. Middle East and Africa Addiction Treatment Market: Top 6 Company Market Share, by Revenue, 2023 27

4.1.4. Middle East and Africa Addiction Treatment Market: Top 3 Company Market Share, by Revenue, 2023 28

4.2. Middle East and Africa Addiction Treatment Market Company Revenue Market Share, 2023 29

4.3. Company Assessment Metrics, 2023 30

4.3.1. Stars 30

4.3.2. Emerging Leaders 30

4.3.3. Pervasive Players 30

4.3.4. Participants 30

4.4. Start-ups /SMEs Assessment Metrics, 2023 30

4.4.1. Progressive Companies 30

4.4.2. Responsive Companies 30

4.4.3. Dynamic Companies 30

4.4.4. Starting Blocks 30

4.5. Strategic Developments 31

4.5.1. Acquisitions & Mergers 31

New Product Launch 31

Middle East and Africa Expansion 31

4.6. Key Players Product Matrix 32

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 33

5.1. PESTEL 33

5.1.1. Political Factors 33

5.1.2. Economic Factors 33

5.1.3. Social Factors 33

5.1.4. Technological Factors 33

5.1.5. Environmental Factors 33

5.1.6. Legal Factors 33

5.2. Adjacent Market Analysis 33

CHAPTER NO. 6 : MIDDLE EAST AND AFRICA ADDICTION TREATMENT MARKET – BY TREATMENT TYPE SEGMENT ANALYSIS 34

6.1. Middle East and Africa Addiction Treatment Market Overview, by Treatment Type Segment 34

6.1.1. Middle East and Africa Addiction Treatment Market Revenue Share, By Treatment Type, 2023 & 2032 35

6.1.2. Middle East and Africa Addiction Treatment Market Attractiveness Analysis, By Treatment Type 36

6.1.3. Incremental Revenue Growth Opportunity, by Treatment Type, 2024 – 2032 36

6.1.4. Middle East and Africa Addiction Treatment Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 37

6.2. Alcohol Addiction Treatment 38

6.3. Tobacco/Nicotine Addiction Treatment 39

6.4. Opioid Addiction Treatment 40

6.5. Other Substances Addiction Treatment 41

CHAPTER NO. 7 : MIDDLE EAST AND AFRICA ADDICTION TREATMENT MARKET – BY DRUG TYPE SEGMENT ANALYSIS 42

7.1. Middle East and Africa Addiction Treatment Market Overview, by Drug Type Segment 42

7.1.1. Middle East and Africa Addiction Treatment Market Revenue Share, By Drug Type, 2023 & 2032 43

7.1.2. Middle East and Africa Addiction Treatment Market Attractiveness Analysis, By Drug Type 44

7.1.3. Incremental Revenue Growth Opportunity, by Drug Type, 2024 – 2032 44

7.1.4. Middle East and Africa Addiction Treatment Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 45

7.2. Bupropion 46

7.3. Varenicline 47

7.4. Acamprosate 48

7.5. Disulfiram 49

7.6. Naltrexone 50

7.7. Methadone 50

7.8. Buprenorphine 51

7.9. Nicotine Replacement Products 51

7.10. Others 52

CHAPTER NO. 8 : MIDDLE EAST AND AFRICA ADDICTION TREATMENT MARKET – BY TREATMENT CENTER SEGMENT ANALYSIS 53

8.1. Middle East and Africa Addiction Treatment Market Overview, by Treatment Centre Segment 53

8.1.1. Middle East and Africa Addiction Treatment Market Revenue Share, By Treatment Center, 2023 & 2032 54

8.1.2. Middle East and Africa Addiction Treatment Market Attractiveness Analysis, By Treatment Center 55

8.1.3. Incremental Revenue Growth Opportunity, by Treatment Center, 2024 – 2032 55

8.1.4. Middle East and Africa Addiction Treatment Market Revenue, By Treatment Center, 2018, 2023, 2027 & 2032 56

8.2. Outpatient Treatment Centers 57

8.3. Residential Treatment Centers 58

8.4. Inpatient Treatment Centers 59

CHAPTER NO. 9 : MIDDLE EAST AND AFRICA ADDICTION TREATMENT MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 60

9.1. Middle East and Africa Addiction Treatment Market Overview, by Distribution Channel Segment 60

9.1.1. Middle East and Africa Addiction Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 61

9.1.2. Middle East and Africa Addiction Treatment Market Attractiveness Analysis, By Distribution Channel 62

9.1.3. Incremental Revenue Growth Opportunity, by Distribution Channel, 2024 – 2032 62

9.1.4. Middle East and Africa Addiction Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 63

9.2. Hospitals Pharmacies 64

9.3. Medical Stores 65

9.4. Others 66

CHAPTER NO. 10 : ADDICTION TREATMENT MARKET – MIDDLE EAST 67

10.1. Middle East 67

10.1.1. Key Highlights 67

10.1.2. Middle East and Africa Addiction Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 68

10.1.3. Middle East and Africa Addiction Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 69

10.1.4. Middle East and Africa Addiction Treatment Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 70

10.1.5. Middle East and Africa Addiction Treatment Market Revenue, By Treatment Center, 2018 – 2023 (USD Million) 71

10.1.6. Middle East and Africa Addiction Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 72

10.2. UAE 73

10.3. KSA 73

10.4. Israel 73

10.5. Turkey 73

10.6. Iran 73

10.7. Egypt 73

10.8. Nigeria 73

10.9. Algeria 73

10.10. Morocco 73

10.11. Rest of Middle East and Africa 73

CHAPTER NO. 11 : COMPANY PROFILES 74

11.1. Teva Pharmaceutical Industries Ltd. 74

11.1.1. Company Overview 74

11.1.2. Product Portfolio 74

11.1.3. Swot Analysis 74

11.1.4. Business Strategy 75

11.1.5. Financial Overview 75

11.2. Pfizer, Inc. 76

11.3. Glenmark Pharmaceuticals 76

11.4. GSK plc 76

11.5. Johnson & Johnson Services, Inc. 76

11.6. Novartis AG 76

11.7. Cipla 76

11.8. Dr. Reddy’s Laboratories Limited 76

11.9. Hikma Pharmaceuticals Plc 76

11.10. Mylan N.V. 76

11.11. Eli Lilly and Company 76

CHAPTER NO. 12 : RESEARCH METHODOLOGY 77

12.1. Research Methodology 77

12.1.1. Phase I – Secondary Research 78

12.1.2. Phase II – Data Modeling 78

Company Share Analysis Model 79

Revenue Based Modeling 79

12.1.3. Phase III – Primary Research 80

12.1.4. Research Limitations 81

Assumptions 81

List of Figures

FIG NO. 1. Middle East and Africa Addiction Treatment Market Revenue, 2018 – 2032 (USD Million) 19

FIG NO. 2. Porter’s Five Forces Analysis for Middle East and Africa Addiction Treatment Market 25

FIG NO. 3. Company Share Analysis, 2023 26

FIG NO. 4. Company Share Analysis, 2023 27

FIG NO. 5. Company Share Analysis, 2023 27

FIG NO. 6. Company Share Analysis, 2023 28

FIG NO. 7. Middle East and Africa Addiction Treatment Market – Company Revenue Market Share, 2023 29

FIG NO. 8. Middle East and Africa Addiction Treatment Market Revenue Share, By Treatment Type, 2023 & 2032 35

FIG NO. 9. Market Attractiveness Analysis, By Treatment Type 36

FIG NO. 10. Incremental Revenue Growth Opportunity by Treatment Type, 2024 – 2032 36

FIG NO. 11. Middle East and Africa Addiction Treatment Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 37

FIG NO. 12. Middle East and Africa Addiction Treatment Market for Alcohol Addiction Treatment, Revenue (USD Million) 2018 – 2032 38

FIG NO. 13. Middle East and Africa Addiction Treatment Market for Tobacco/Nicotine Addiction Treatment, Revenue (USD Million) 2018 – 2032 39

FIG NO. 14. Middle East and Africa Addiction Treatment Market for Opioid Addiction Treatment, Revenue (USD Million) 2018 – 2032 40

FIG NO. 15. Middle East and Africa Addiction Treatment Market for Other Substances Addiction Treatment, Revenue (USD Million) 2018 – 2032 41

FIG NO. 16. Middle East and Africa Addiction Treatment Market Revenue Share, By Drug Type, 2023 & 2032 43

FIG NO. 17. Market Attractiveness Analysis, By Drug Type 44

FIG NO. 18. Incremental Revenue Growth Opportunity by Drug Type, 2024 – 2032 44

FIG NO. 19. Middle East and Africa Addiction Treatment Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 45

FIG NO. 20. Middle East and Africa Addiction Treatment Market for Bupropion, Revenue (USD Million) 2018 – 2032 46

FIG NO. 21. Middle East and Africa Addiction Treatment Market for Varenicline, Revenue (USD Million) 2018 – 2032 47

FIG NO. 22. Middle East and Africa Addiction Treatment Market for Acamprosate, Revenue (USD Million) 2018 – 2032 48

FIG NO. 23. Middle East and Africa Addiction Treatment Market for Disulfiram, Revenue (USD Million) 2018 – 2032 49

FIG NO. 24. Middle East and Africa Addiction Treatment Market for Naltrexone, Revenue (USD Million) 2018 – 2032 50

FIG NO. 25. Middle East and Africa Addiction Treatment Market for Methadone, Revenue (USD Million) 2018 – 2032 50

FIG NO. 26. Middle East and Africa Addiction Treatment Market for Buprenorphine, Revenue (USD Million) 2018 – 2032 51

FIG NO. 27. Middle East and Africa Addiction Treatment Market for Nicotine Replacement Products, Revenue (USD Million) 2018 – 2032 51

FIG NO. 28. Middle East and Africa Addiction Treatment Market for Others, Revenue (USD Million) 2018 – 2032 52

FIG NO. 29. Middle East and Africa Addiction Treatment Market Revenue Share, By Treatment Center, 2023 & 2032 54

FIG NO. 30. Market Attractiveness Analysis, By Treatment Center 55

FIG NO. 31. Incremental Revenue Growth Opportunity by Treatment Center, 2024 – 2032 55

FIG NO. 32. Middle East and Africa Addiction Treatment Market Revenue, By Treatment Center, 2018, 2023, 2027 & 2032 56

FIG NO. 33. Middle East and Africa Addiction Treatment Market for Outpatient Treatment Centers, Revenue (USD Million) 2018 – 2032 57

FIG NO. 34. Middle East and Africa Addiction Treatment Market for Residential Treatment Centers, Revenue (USD Million) 2018 – 2032 58

FIG NO. 35. Middle East and Africa Addiction Treatment Market for Inpatient Treatment Centers, Revenue (USD Million) 2018 – 2032 59

FIG NO. 36. Middle East and Africa Addiction Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 61

FIG NO. 37. Market Attractiveness Analysis, By Distribution Channel 62

FIG NO. 38. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 62

FIG NO. 39. Middle East and Africa Addiction Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 63

FIG NO. 40. Middle East and Africa Addiction Treatment Market for Hospitals Pharmacies, Revenue (USD Million) 2018 – 2032 64

FIG NO. 41. Middle East and Africa Addiction Treatment Market for Medical Stores, Revenue (USD Million) 2018 – 2032 65

FIG NO. 42. Middle East and Africa Addiction Treatment Market for Others, Revenue (USD Million) 2018 – 2032 66

FIG NO. 43. Middle East and Africa Addiction Treatment Market Revenue, 2018 – 2032 (USD Million) 67

FIG NO. 44. Research Methodology – Detailed View 77

FIG NO. 45. Research Methodology 78

List of Tables

TABLE NO. 1. : Middle East and Africa Addiction Treatment Market: Snapshot 17

TABLE NO. 2. : Drivers for the Middle East and Africa Addiction Treatment Market: Impact Analysis 21

TABLE NO. 3. : Restraints for the Middle East and Africa Addiction Treatment Market: Impact Analysis 23

TABLE NO. 4. : Middle East and Africa Addiction Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 68

TABLE NO. 5. : Middle East and Africa Addiction Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 68

TABLE NO. 6. : Middle East and Africa Addiction Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 69

TABLE NO. 7. : Middle East and Africa Addiction Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 69

TABLE NO. 8. : Middle East and Africa Addiction Treatment Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 70

TABLE NO. 9. : Middle East and Africa Addiction Treatment Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 70

TABLE NO. 10. : Middle East and Africa Addiction Treatment Market Revenue, By Treatment Center, 2018 – 2023 (USD Million) 71

TABLE NO. 11. : Middle East and Africa Addiction Treatment Market Revenue, By Treatment Center, 2024 – 2032 (USD Million) 71

TABLE NO. 12. : Middle East and Africa Addiction Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 72

TABLE NO. 13. : Middle East and Africa Addiction Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 72

Frequently Asked Questions:

What is the projected growth of the Middle East and Africa addiction treatment market?

The market is expected to grow from USD 241.01 million in 2023 to USD 352.30 million by 2032, with a CAGR of 4.11% from 2024 to 2032.

What are the main drivers of market growth?

Key drivers include rising substance abuse incidences, increased government funding, and growing public awareness of addiction as a medical condition.

Which regions hold significant market shares in the Middle East and Africa?

The GCC countries hold about 40% of the market share, followed by South Africa at 25%, with the remaining share spread across other regions.

How is the integration of mental health services impacting the market?

Integrating mental health services with addiction treatment programs is improving patient outcomes by addressing co-occurring disorders comprehensively.

What role does telemedicine play in addiction treatment?

Telemedicine enhances accessibility to counseling and therapy, especially in rural areas, making addiction treatment more convenient and effective for patients.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –